These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

690 related items for PubMed ID: 10541353

  • 1. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
    Behr TM, Béhé M, Angerstein C, Gratz S, Mach R, Hagemann L, Jenner N, Stiehler M, Frank-Raue K, Raue F, Becker W.
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353
    [Abstract] [Full Text] [Related]

  • 2. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M, Behr TM.
    Biopolymers; 2002 Oct; 66(6):399-418. PubMed ID: 12658727
    [Abstract] [Full Text] [Related]

  • 3. Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors.
    Behr TM, Jenner N, Béhé M, Angerstein C, Gratz S, Raue F, Becker W.
    J Nucl Med; 1999 Jun; 40(6):1029-44. PubMed ID: 10452322
    [Abstract] [Full Text] [Related]

  • 4. Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies.
    Behr TM, Béhé MP.
    Semin Nucl Med; 2002 Apr; 32(2):97-109. PubMed ID: 11965605
    [Abstract] [Full Text] [Related]

  • 5. Targeting of cholecystokinin-B/gastrin receptors in vivo: preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabelled gastrin.
    Behr TM, Jenner N, Radetzky S, Béhe M, Gratz S, Yücekent S, Raue F, Becker W.
    Eur J Nucl Med; 1998 Apr; 25(4):424-30. PubMed ID: 9553173
    [Abstract] [Full Text] [Related]

  • 6. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
    von Guggenberg E, Behe M, Behr TM, Saurer M, Seppi T, Decristoforo C.
    Bioconjug Chem; 2004 Apr; 15(4):864-71. PubMed ID: 15264875
    [Abstract] [Full Text] [Related]

  • 7. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.
    Reubi JC, Schaer JC, Waser B.
    Cancer Res; 1997 Apr 01; 57(7):1377-86. PubMed ID: 9102227
    [Abstract] [Full Text] [Related]

  • 8. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW, Holladay MW, Barrett RW, Wolfram CA, Miller TR, Witte D, Kerwin JF, Wagenaar F, Nadzan AM.
    Mol Pharmacol; 1989 Dec 01; 36(6):881-6. PubMed ID: 2601685
    [Abstract] [Full Text] [Related]

  • 9. Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy.
    de Jong M, Bakker WH, Bernard BF, Valkema R, Kwekkeboom DJ, Reubi JC, Srinivasan A, Schmidt M, Krenning EP.
    J Nucl Med; 1999 Dec 01; 40(12):2081-7. PubMed ID: 10616889
    [Abstract] [Full Text] [Related]

  • 10. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization.
    Zhou W, Povoski SP, Longnecker DS, Bell RH.
    Cancer Res; 1992 Dec 15; 52(24):6905-11. PubMed ID: 1458479
    [Abstract] [Full Text] [Related]

  • 11. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
    Zhou W, Povoski SP, Bell RH.
    J Surg Res; 1995 Mar 15; 58(3):281-9. PubMed ID: 7533864
    [Abstract] [Full Text] [Related]

  • 12. Cyclic minigastrin analogues for gastrin receptor scintigraphy with technetium-99m: preclinical evaluation.
    von Guggenberg E, Sallegger W, Helbok A, Ocak M, King R, Mather SJ, Decristoforo C.
    J Med Chem; 2009 Aug 13; 52(15):4786-93. PubMed ID: 19591486
    [Abstract] [Full Text] [Related]

  • 13. Stabilized (111)in-labeled sCCK8 analogues for targeting CCK2-receptor positive tumors: synthesis and evaluation.
    Roosenburg S, Laverman P, Joosten L, Eek A, Oyen WJ, de Jong M, Rutjes FP, van Delft FL, Boerman OC.
    Bioconjug Chem; 2010 Apr 21; 21(4):663-70. PubMed ID: 20302291
    [Abstract] [Full Text] [Related]

  • 14. Antiserum raised against an epitope of the cholecystokinin B/gastrin receptor inhibits hepatic invasion of a human colon tumor.
    Watson SA, Clarke PA, Morris TM, Caplin ME.
    Cancer Res; 2000 Oct 15; 60(20):5902-7. PubMed ID: 11059789
    [Abstract] [Full Text] [Related]

  • 15. Radiolabeling approaches for cholecystokinin B receptor imaging.
    Aloj L, Panico MR, Caracó C, Zannetti A, Del Vecchio S, Di Nuzzo C, Arra C, Morelli G, Tesauro D, De Luca S, Pedone C, Salvatore M.
    Biopolymers; 2002 Oct 15; 66(6):370-80. PubMed ID: 12658724
    [Abstract] [Full Text] [Related]

  • 16. CCK receptors in human neuroendocrine tumors: clinical implications.
    Reubi JC.
    Scand J Clin Lab Invest Suppl; 2001 Oct 15; 234():101-4. PubMed ID: 11713969
    [Abstract] [Full Text] [Related]

  • 17. Identification of cholecystokinin-B/gastrin receptor domains that confer high gastrin affinity: utilization of a novel Xenopus laevis cholecystokinin receptor.
    Schmitz F, Pratt DS, Wu MJ, Kolakowski LF, Beinborn M, Kopin AS.
    Mol Pharmacol; 1996 Aug 15; 50(2):436-41. PubMed ID: 8700154
    [Abstract] [Full Text] [Related]

  • 18. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
    Schottelius M, Berger S, Poethko T, Schwaiger M, Wester HJ.
    Bioconjug Chem; 2008 Jun 15; 19(6):1256-68. PubMed ID: 18510351
    [Abstract] [Full Text] [Related]

  • 19. Gastrin and cholecystokinin peptide-based radiopharmaceuticals: an in vivo and in vitro comparison.
    Tornesello AL, Aurilio M, Accardo A, Tarallo L, Barbieri A, Arra C, Tesauro D, Morelli G, Aloj L.
    J Pept Sci; 2011 May 15; 17(5):405-12. PubMed ID: 21351319
    [Abstract] [Full Text] [Related]

  • 20. Unexpected high incidence of cholecystokinin-B/gastrin receptors in human medullary thyroid carcinomas.
    Reubi JC, Waser B.
    Int J Cancer; 1996 Sep 04; 67(5):644-7. PubMed ID: 8782652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.